Found: 23
Select item for more details and to access through your institution.
Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment.
- Published in:
- Medical Principles & Practice, 2015, v. 24, n. 5, p. 458, doi. 10.1159/000433472
- By:
- Publication type:
- Article
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 6, p. 849, doi. 10.1111/ijlh.13299
- By:
- Publication type:
- Article
Efficacy, safety, and survival findings after long‐term follow‐up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 774, doi. 10.1002/ajh.27245
- By:
- Publication type:
- Article
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor‐naïve patients with myelofibrosis: Results of a phase II trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1510, doi. 10.1002/ajh.26709
- By:
- Publication type:
- Article
Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/4052591
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
- Published in:
- Molecular & Cellular Biochemistry, 2024, v. 479, n. 11, p. 3077, doi. 10.1007/s11010-023-04906-w
- By:
- Publication type:
- Article
Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 13885, doi. 10.1002/cam4.5922
- By:
- Publication type:
- Article
Long non-coding RNA DANCR represses the viability, migration and invasion of multiple myeloma cells by sponging miR-135b-5p to target KLF9.
- Published in:
- Molecular Medicine Reports, 2021, v. 24, n. 3, p. N.PAG, doi. 10.3892/mmr.2021.12288
- By:
- Publication type:
- Article
Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.707191
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
Endocan, a potential prognostic and diagnostic biomarker of acute leukemia.
- Published in:
- Molecular & Cellular Biochemistry, 2014, v. 395, n. 1/2, p. 117, doi. 10.1007/s11010-014-2117-0
- By:
- Publication type:
- Article
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 206, doi. 10.1002/ajh.22211
- By:
- Publication type:
- Article
Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4777, doi. 10.2147/CMAR.S253367
- By:
- Publication type:
- Article
Anti-CD19 chimeric antigen receptor T-cell followed by interferon−a therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021786
- By:
- Publication type:
- Article
iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.822805
- By:
- Publication type:
- Article
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.921587
- By:
- Publication type:
- Article
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.879471
- By:
- Publication type:
- Article
LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β‐catenin/cyclin D1 signaling via PLAGL2.
- Published in:
- Cell Biology & Toxicology, 2022, v. 38, n. 6, p. 979, doi. 10.1007/s10565-021-09628-7
- By:
- Publication type:
- Article
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
- Published in:
- Oncology Reports, 2023, v. 49, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Mechanisms underlying the increased chemosensitivity of bortezomib-resistant multiple myeloma by silencing nuclear transcription factor Snail1.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 415, doi. 10.3892/or.2018.6797
- By:
- Publication type:
- Article